Brief: Starpharma Holdings Announces Collaboration And License Agreement With Genentech
22/09/2025 02:15
Sept 22 (Reuters) - Starpharma Holdings Ltd SPL.AX: ANNOUNCES COLLABORATION AND LICENSE AGREEMENT WITH GENENTECH TO RECEIVE $5.5 MILLION UPFRONT, ELIGIBLE FOR UPTO $564 MILLION AGREEMENT TO DEVELOP INNOVATIVE DEP CANCER THERAPIES Further company coverage: SPL.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Starpharma Holdings
See all newsBrief: Starpharma Increases Stake In Petalion To 66% Securing Majority Ownership
Brief: Starpharma Seeks Trading Halt
Brief: Starpharma Holdings Appoints Russell Basser As Chair
Brief: Starpharma Says Fully Underwritten Entitlement Offer To Raise A$32 MLN
Australia's Starpharma slumps to 1-1/2-month low on discounted fund raising